Oxford Nanopore Technologies plc (LON: ONT)
London
· Delayed Price · Currency is GBP · Price in GBp
155.00
+6.50 (4.38%)
Jan 21, 2025, 6:37 PM BST
LON: ONT Revenue
Oxford Nanopore Technologies had revenue of 84.08M GBP in the half year ending June 30, 2024, a decrease of -31.28%. This brings the company's revenue in the last twelve months to 167.75M, up 3.38% year-over-year. In the year 2023, Oxford Nanopore Technologies had annual revenue of 169.67M, down -14.57%.
Revenue (ttm)
167.75M
Revenue Growth
+3.38%
P/S Ratio
7.87
Revenue / Employee
130.95K
Employees
1,238
Market Cap
1.48B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 169.67M | -28.94M | -14.57% |
Dec 31, 2022 | 198.60M | 64.94M | 48.59% |
Dec 31, 2021 | 133.66M | 19.80M | 17.39% |
Dec 31, 2020 | 113.86M | 61.80M | 118.70% |
Dec 31, 2019 | 52.06M | 19.54M | 60.08% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
GSK plc | 31.31B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
ConvaTec Group | 1.74B |
Hikma Pharmaceuticals | 2.39B |
HUTCHMED (China) | 483.31M |
Indivior | 881.89M |
Oxford Nanopore Technologies News
- 8 days ago - UK Stock Market News: PageGroup, Oxford Nanopore, Entain - The Armchair Trader
- 2 months ago - Oxford Nanopore and UK Biobank to create world's first epigenetic dataset targeting the causes of cancer, dementia, complex disease - Business Wire
- 2 months ago - UK health agencies join with Oxford Nanopore to speed up pathogen screening - Financial Times
- 2 months ago - Oxford Nanopore Announces Landmark UK Government Partnership to Advance Genomics-Driven Healthcare Innovation in the UK - Business Wire
- 5 months ago - Half Year 2024 Oxford Nanopore Technologies PLC Earnings Presentation Transcript - GuruFocus
- 5 months ago - Oxford Nanopore reports 1H results - Seeking Alpha
- 5 months ago - Oxford Nanopore Eyes FTSE 250 Inclusion to Widen Investor Base - BNN Bloomberg
- 5 months ago - Oxford Nanopore Technologies plc (ONTTF) Q2 2024 Earnings Call Transcript - Seeking Alpha